Table 2 Pathogenic and likely pathogenic variants (CNVs, aneuploidies and SNVs) identified in different types of CHD based on the Botto classification.
Specific, detailed groups | Simple (%) | Association (%) | Complex (%) | Total cases(%) | Positive rate of CNVs & aneuploidies (%) | Positive rate of SNVs(%) | Total detection rate of CNVs, aneuploidies and SNVs (%) |
|---|---|---|---|---|---|---|---|
Conotruncal | 6(5.9) | 5(5) | 11(10.9) | 3(27.3) | 0(0) | 3(27.3) | |
d-TGA-IVS | 1 | 1 | 0 (0) | 0(0) | 0(0) | ||
TOF | 5 | 5 | 10 | 3(30) | 0(0) | 3(30) | |
Atrioventricular septal defect | 12(11.9) | 2(2) | 14(13.9) | 4(28.6) | 1(7.1) | 5(35.7) | |
AVSD, complete | 1 | 2 | 3 | 2(66.7) | 0(0) | 2(66.7) | |
TAPVR | 10 | 10 | 2(20.0) | 1(10) | 3(30) | ||
PAPVR | 1 | 1 | 0(0) | 0(0) | 0(0) | ||
Left ventricular outflow tract obstruction | 1(1) | 2(2) | 3(3) | 1(33.3) | 0(0) | 1(33.3) | |
IAA, B | 1 | 2 | 3 | 1(33.3) | 0(0) | 1(33.3) | |
Right ventricular outflow tract obstruction | 4(4) | 4(4) | 0(0) | 0(0) | 0(0) | ||
PVS | 1 | 1 | 0(0) | 0(0) | 0(0) | ||
PA-VSD (not TOF anatomy) | 2 | 2 | 0(0) | 0(0) | 0(0) | ||
PA-IVS | 1 | 1 | 0(0) | 0(0) | 0(0) | ||
Septal | 39(38.6) | 18(17.8) | 57(56.4) | 13(22.8) | 5(8.8) | 18(31.6) | |
VSD pm | 28 | 14 | 42 | 9(21.4) | 4(9.5) | 13(31) | |
VSD os | 4 | 2 | 6 | 1(16.7) | 0(0) | 1(16.7) | |
VSD musc | 1 | 1 | 0(0) | 0(0) | 0(0) | ||
ASD2 | 4 | 2 | 6 | 3(50) | 1(16.7) | 4(66.7) | |
ASD nos | 2 | 2 | 0(0) | 0(0) | 0(0) | ||
Single ventricle/Complex | 1(1) | 1(1) | 0(0) | 0(0) | 0(0) | ||
Single ventricle (SV) | 1 | 1 | 0(0) | 0(0) | 0(0) | ||
Septal + LVOTO | 2(2) | 4(4) | 1(1) | 7(7) | 0(0) | 1(14.3) | 1(14.3) |
VSD (noninlet) + COA | 2 | 4 | 1 | 7 | 0(0) | 1(14.3) | 1(14.3) |
Septal + RVOTO | 3(3) | 1(1) | 4(4) | 0(0) | 1(25) | 1(25) | |
ASD + PVS | 3 | 1 | 4 | 0(0) | 1(25) | 1(25) | |
Total | 67 (66.3) | 30(29.7) | 4(4) | 101 | 21(20.8) | 8(7.9) | 29(28.7) |